Tesa/CJC-1295 no DAC/Ipamorelin 6 mg/3 mg/3 mg
Triple-pathway GH secretagogue blend — three synergistic peptides in one vial. ≥98% purity, lyophilized. For laboratory research only.
🎟️ Available Coupons
AURA-BOGO 🛍️ Frequently Bought Together
- Dispatch within 24-48 Hours : Your product will be shipped quickly.
Description
Research Profile
By engaging three distinct but synergistic GH-releasing pathways — Tesamorelin’s direct GHRH receptor agonism, CJC-1295’s stabilized GHRH analog activity, and Ipamorelin’s selective ghrelin receptor engagement — this blend enables comprehensive study of amplified, pulsatile GH release. The triple-pathway approach allows researchers to investigate receptor cross-talk and additive signaling dynamics across the somatotropic axis.









Reviews
There are no reviews yet.